[1] Gengshu Wei, Enlin Zhu, Xin Wang, et al. Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2020, (预出版): 36-40.
Feasibility of Yiqi Xuanbi Decoctionin treating pulmonary fibro - sisafter new crown pneumonia
- Keywords:
- Novel coronavirus pneumonia; Pulmonary fibrosis; Deficiency and excess; Yiqi Xuanbi Decoction
- Abstract:
- With novel coronavirus pneumonia meeting the discharge standard, patients gradually increase. After novel coronavirus pneumonia, the treatment of pulmonary fibrosis tends to be emphasized. Literature review, and novel coronavirus pneumonia after the analysis of the clinical characteristics and TCM classification of lung fibrosis. It was found that the patients in the recovery period were deficiency of lung qi and spleen or deficiency of both qi and Yin, Phlegm and blood stasis block collaterals, The pathogenesis of the disease is mixed with deficiency and excess, and the lung qi is not clear.
References:
[1]刘清泉,夏文广,安长青,等.中西医结合治疗新型冠状病毒肺炎作用的思考[J/OL].中医杂志.http://kns.cnki.net/kcms/detail/11.2166.R.20200215.1057.002.html.
[2]郑文科,张俊华,杨丰文,等.中医药防治新型冠状病毒感染的肺炎各地诊疗方案综合分析[J/OL].中医杂志,2020.(2020-02-06)[2020-02-14].http://kns.cnki.net/Kcms/detail/11.2166.r.20200206.1113.002.html.
[3]王玉光,齐文升,马家驹,等.新型冠状病毒(2019-nCoV)肺炎中医临床特征与辨证治疗初探[J/OL].中医杂志.http://kns.cnki.net/kcms/detail/11.2166.R.20200129.1258.002.html
[4]苗青,丛晓东,王冰,王玉光,张忠德.新型冠状病毒感染的肺炎的中医认识与思考[J/OL].中医杂志.http://kns.cnki.net/kcms/detail/11.2166.R.20200205.1606.002.html
[5]钟飞扬,张寒菲,等,新型冠状病毒肺炎的CT影像学表现[J].武汉大学学报(医学版).http://kns.cnki.net/kcms/detail/42.1677.R.20200213.1408.001.html
[6] Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin [J/OL] . Nature, 2020. Doi: 10. 1038/ s41586 - 020 -2012 -7.
[7]彭如臣,单锐,史英,等.SARS患者骨缺血性坏死的MRI检查[J].临床放射学杂志,2004,23(4):318-320.
[8] Mckee M D, Waddell J P , kuclo P A, et al. Oste onecrosis of the femoral head in men following short course cortic osteroid therapy: a report of 15 cases [ J] . CMA J,2001, 164: 205.
[9]杨淦,张先元,曹桅,等.特发性肺纤维化与肺痹?肺萎关系浅析[J].亚太传统医药,2015.11(2):52一53
[10]中华人民共和国中央人民政府.仝小林院士“解读”《新型冠状病毒感染的肺炎诊疗方案(试行第四版)》中的中医治疗方案[EB/OL].(2020-01-28)[2020-02-12].http://www.gov.cn/zhengce/2020-01/28/content_5472789.htm.
[11]范佳琳,张诗军.“因湿致瘀”理论研究进展[J].深圳中西医结合杂志,2008,10(5):317-320.
[12]袁洪霞,陈艳春.黄芪的现代药理研究及其临床应用[J].山东中医药大学学报,2000,9(5):397-399
[13]蔺兴遥,张毅,李娟,等.黄茂黄酮与红茂黄酮对肺间质纤维化模型大鼠肺功能影响的对比研究[J].中成药,2013,35(8):1770-1773..
[14]王慧,袁德培,曾楚华,陈壮.黄精的药理作用及临床应用研究进展[J].湖北民族学院学报(医学版),2017,34(2):58-60+64.
[15]周二付.地龙的现代药理及常见临床配伍分析[J].中国现代药物应用,2014,8(3):238-239.
[16]王秀华,刘爱东,徐彩云.鸡血藤抗血栓形成作用的研究[J].长春中医学院学报,2005,5(04):41.
[17]王薇.赤芍化学成分和药理作用的研究进展[J].黑龙江科技信息,2015(17):109.
Memo
通讯作者:魏耕树,主任医师?E-mail:zhuenlin2013@163.com